This is a common concern for patients considering GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
Plausible signaling is a starting point for investigation, not a substitute for human safety and efficacy data
Dose-Dependent Efficacy and Safety of Tirzepatide for Weight Loss in Non-diabetic Adults With Obesity: a Systematic Review and M eta-analysis of Randomized Controlled Trials
We used the same set of claims and a charge inflation factor of 11.3 percent (1.11313) and the CCRs in the July 2025 OPSF, with an adjustment of 0.956081 (90 FR 37227), to reflect relative changes in cost and charge inflation between CY 2025 and CY 2026, to model the final CY 2026 outliers at 1.0 percent of estimated total payments using a multiple threshold of 1.75 and a fixed dollar threshold of $6,225
Mochi Health is a telehealth company based in San Francisco that connects patients with licensed providers for weight loss treatment, including compounded and brand-name GLP-1 medications like tirzepatide and semaglutide